Derivados selenados como terapia frente a cáncer, tripanosomas y otras patologías
SECALE
University of Kent
Canterbury, Reino UnidoPublications en collaboration avec des chercheurs de University of Kent (2)
2021
-
Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion
Pharmaceuticals, Vol. 14, Núm. 5
-
Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies
ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738